Houthoff Buruma advised BGI Genomics Co., Ltd. in all Dutch-law aspects in connection with its successful IPO at the Shenzhen Stock Exchange. BGI is a leading gene sequencing firm, offering a wide portfolio of genetic testing products across major diseases, enabling medical providers and patients worldwide to realize the promise of genomics-based diagnostics and personalized healthcare.
Houthoff Buruma team included: Michiel Wesseling , André de Neve , Helena Sprenger , Richard Witvliet , William Guo , Anne Alkemade , Joost Kool , Gerard van der Linden , Anouk Boutens